Gjersdal, Erlend http://orcid.org/0009-0009-1391-8009
Larsen, Liva Bundgaard
Ettrup, Kåre Schmidt
Vestergaard, Peter
Nielsen, Eigil Husted
Karmisholt, Jesper Scott
Müller, Hermann L.
Dal, Jakob
Funding for this research was provided by:
Aalborg University Hospital
Article History
Accepted: 3 July 2024
First Online: 1 August 2024
Declarations
:
: Informed consent was obtained from all individual participants in the study.
: E.G., L.B.L., E.H.N., J.S.K. and K.S.E. have no competing interests to declare that are relevant to the content of this article. P.V. is head of research at the Steno Diabetes Center North Denmark, funded by an unrestricted grant by the Novo Nordisk Foundation. H.L.M. has received reimbursement of participation fees for scientific meetings and continuing medical education events from the following companies: Ferring, Pfizer, Sandoz/Hexal, Novo Nordisk, IPSEN, Rhythm Pharmaceuticals, and Merck Serono. He has also received reimbursement of travel expenses from Merck Serono, Rhythm Pharmaceuticals, and IPSEN and a lecture honoraria from Pfizer. J.D. has received unrestricted research grants from IPSEN and Pfizer.